APA (7th ed.) Citation

O, C., F, M., G, E., L, C., A, M., R, G. L., . . . G, R. (2023). Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients. Medicina (Kaunas, Lithuania), 59(8), . https://doi.org/10.3390/medicina59081362

Chicago Style (17th ed.) Citation

O, Capdevila, et al. "Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients." Medicina (Kaunas, Lithuania) 59, no. 8 (2023). https://doi.org/10.3390/medicina59081362.

MLA (9th ed.) Citation

O, Capdevila, et al. "Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients." Medicina (Kaunas, Lithuania), vol. 59, no. 8, 2023, https://doi.org/10.3390/medicina59081362.